A recent development in women's health research has resulted in the renaming of a condition. Polycystic ovarian syndrome is now known as polyendocrine metabolic ovarian syndrome. This change comes after 14 years of collaboration and input from researchers and patients. The new name reflects a more accurate understanding of the condition, which affects one in eight women worldwide. It is a complex disorder involving hormones, metabolism, and endocrine function, rather than just a issue with the ovaries. Further details about this change and its implications are available from the source, which provides more information on the research and collaboration that led to the renaming of the condition.
global
What the PCOS-PMOS Rebrand Tells Us About the State of Women’s Health Research
A recent development in women's health research has resulted in the renaming of a condition. Polycystic ovarian syndrome is now known as polyendocrine metabolic ovarian syndrome. This change comes aft
